Trials / Completed
CompletedNCT00525382
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
A Study Evaluating the Efficacy and Safety of 5 mg Levocetirizine Oral Tablets, Once Daily Versus 10 mg Loratadine Oral Tablets, Once Daily for the Treatment of Chronic Idiopathic Urticaria (CIU)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine dihydrochloride |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2007-09-05
- Last updated
- 2013-12-12
Source: ClinicalTrials.gov record NCT00525382. Inclusion in this directory is not an endorsement.